mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0005 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |